基本信息
浏览量:1
职业迁徙
个人简介
She is an internationally recognized expert in cancer drug discovery. Dr. Leopold’s research interests are focused on the discovery and development of rationally designed kinase inhibitors to target adaptive resistance mechanisms in cancer cells. She pioneered the MEK inhibitor field, advancing the field’s first MEK inhibitor into the clinic. Her laboratory at Michigan Medicine continues to focus on first-in-class drug opportunities designed to offer combination therapy to a broad range of cancer patients treated in multiple settings, including radiotherapy.
研究兴趣
论文共 26 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
COMPLEX NETWORKS (2) (2019): 751-761
mag(2013)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn